Editorial: Cancer Prevention: Targeting Premalignant Epithelial Neoplasms in the Era of Cancer Immunotherapy and Vaccines

• Nicolas Çuburu,
• Olivera J. Finn,
• Sjoerd H. Van Der Burg

Affiliations

Nicolas Çuburu

Laboratory of Cellular Oncology, Center for Cancer Research, National Cancer Institute (NIH), Bethesda, MA, United States

Olivera J. Finn

Department of Immunology, School of Medicine, University of Pittsburgh, Pittsburgh, PA, United States

Sjoerd H. Van Der Burg

Department of Medical Oncology, Leiden University Medical Center, Leiden, Netherlands